Beyond PARP inhibition: pathways of potential clinical relevance and targeted treatments in ovarian cancer


E-session 521

Expert
Ilaria Colombo'
Medical oncologist
Oncology Institute of Southern Switzerland (IOSI)
Bellinzona, Switzerland
Discussant
Anastasios Stathis'
Oncology Institute of Southern Switzerland
Bellinzona, Switzerland

This e-Session is part of the following pathway(s):
02
Apr 2020